Intended for healthcare professionals

  1. Research
  2. Differential dropout...
  3. Differential dropout and bias in randomised controlled trials: when it matters and when it may not
Research Methods & Reporting

Differential dropout and bias in randomised controlled trials: when it matters and when it may not

BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.e8668 (Published 21 January 2013) Cite this as: BMJ 2013;346:e8668

Data supplement

  • Web Extra

    Extra material supplied by the author

    Files in this Data Supplement:

Related articles

See more

Cited by...

  • Prevalence and impact of exercise-induced laryngeal obstruction in asthma: a study protocol for a cross-sectional and longitudinal study
  • Mechanisms of chiropractic spinal manipulative therapy for patients with chronic primary low back pain: protocol for a mechanistic randomised placebo-controlled trial
  • Study protocol for double-blind, randomised placebo-controlled trial evaluating semitendinosus function and morbidity following tendon harvesting for anterior cruciate ligament reconstruction augmented by platelet-rich plasma
  • Evaluating the feasibility of a web-based discharge education programme to improve general surgical patients postdischarge recovery: a pilot randomised controlled trial
  • Feasibility and safety of an immersive virtual reality-based vestibular rehabilitation programme in people with multiple sclerosis experiencing vestibular impairment: a protocol for a pilot randomised controlled trial
  • Modeling Clinical Trial Attrition Using Machine Intelligence: A driver analytics case study using 1,325 trials representing one million patients
  • Experiences of trial participants and site staff of participating in and running a large randomised trial within fertility (the endometrial scratch trial): a qualitative interview study
  • Missing data in randomised controlled trials of rheumatoid arthritis drug therapy are substantial and handled inappropriately
  • The Quality of Randomized Controlled Trials in High-impact Rheumatology Journals, 1998-2018
  • Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis
  • HORIZONS protocol: a UK prospective cohort study to explore recovery of health and well-being in adults diagnosed with cancer
  • Electroacupuncture plus standard of care for managing refractory functional dyspepsia: protocol of a pragmatic trial with economic evaluation
  • Reflections From a Statistical Editor: Elements of Great Manuscripts
  • Health-Related Quality of Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma
  • Reduction of the n-6:n-3 long-chain PUFA ratio during pregnancy and lactation on offspring body composition: follow-up results from a randomized controlled trial up to 5 y of age
  • Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
  • Intensive Versus Intermediate Glucose Control in Surgical Intensive Care Unit Patients
  • Effect of Ischemic Postconditioning on Infarct Size in Patients With ST-Elevation Myocardial Infarction Treated by Primary PCI Results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) Randomized Trial
Back to top